COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 427
Retesting Timeline
Generally, retesting Array 5 is recommended after 6-12 months of
intervention to assess progress and guide ongoing treatment [52].
Progress Indicators
Decreasing antibody levels, particularly accompanied by
symptom improvement, suggest successful intervention [53].
Persistent Elevations
If antibodies remain elevated despite intervention, this suggests
the need to investigate additional triggers or modify the treatment
approach [54].
Conclusion: The Value of Predictive Autoimmune Testing
Array 5 represents a significant advancement in the assessment
and management of autoimmune risk. By identifying predictive
antibodies before tissue damage has progressed to the point of
diagnosable disease, Array 5 creates a critical window for
preventive intervention that may significantly alter autoimmune
outcomes.
The traditional medical approach to autoimmunity4waiting for
disease to fully manifest before intervention4often means that
treatment begins only after irreversible tissue damage has
occurred. Array 5 enables a paradigm shift toward earlier
detection and more preventive approaches that address root
causes rather than merely managing symptoms.
As research in this field continues to evolve, our understanding of
predictive autoimmunity and effective early interventions will
continue to advance. For now, Array 5 provides a valuable tool for
clinicians seeking to identify autoimmune processes in their
earliest, most reversible stages, offering hope for preventing or
minimizing the impact of these challenging conditions.
427
